DK0667920T3 - Fremgangsmåder til påvisning af prostatacancermetastase - Google Patents

Fremgangsmåder til påvisning af prostatacancermetastase

Info

Publication number
DK0667920T3
DK0667920T3 DK93925095T DK93925095T DK0667920T3 DK 0667920 T3 DK0667920 T3 DK 0667920T3 DK 93925095 T DK93925095 T DK 93925095T DK 93925095 T DK93925095 T DK 93925095T DK 0667920 T3 DK0667920 T3 DK 0667920T3
Authority
DK
Denmark
Prior art keywords
prostate cancer
methods
cancer metastasis
detecting prostate
rna
Prior art date
Application number
DK93925095T
Other languages
Danish (da)
English (en)
Inventor
Carlo Croce
Leonard Gomella
Grant S Mulholland
Jose G Moreno
Rainer Fischer
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of DK0667920T3 publication Critical patent/DK0667920T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93925095T 1992-10-29 1993-10-27 Fremgangsmåder til påvisning af prostatacancermetastase DK0667920T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97332292A 1992-10-29 1992-10-29
PCT/US1993/010331 WO1994010343A1 (en) 1992-10-29 1993-10-27 Methods of detecting micrometastasis of prostate cancer

Publications (1)

Publication Number Publication Date
DK0667920T3 true DK0667920T3 (da) 2003-04-14

Family

ID=25520753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93925095T DK0667920T3 (da) 1992-10-29 1993-10-27 Fremgangsmåder til påvisning af prostatacancermetastase

Country Status (10)

Country Link
US (2) US5506106A (de)
EP (1) EP0667920B1 (de)
JP (1) JPH08502889A (de)
AT (1) ATE231187T1 (de)
CA (1) CA2148350A1 (de)
DE (1) DE69332642T2 (de)
DK (1) DK0667920T3 (de)
ES (1) ES2191018T3 (de)
PT (1) PT667920E (de)
WO (1) WO1994010343A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
DE69332642T2 (de) * 1992-10-29 2003-10-02 Thomas Jefferson University, Philadelphia Methoden zur detektion von mikrometastasen bei prostata-krebs
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
WO1995028498A1 (en) * 1994-04-15 1995-10-26 The Trustees Of Columbia University In The City Of New York Method for molecular staging of prostate cancer
CA2189774A1 (en) * 1994-05-10 1995-11-16 Donald J. Tindall Recombinant hk2 polypeptide
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
WO1996021042A2 (en) * 1995-01-04 1996-07-11 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6218529B1 (en) 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
EP0951541B1 (de) * 1995-07-31 2005-11-30 Urocor, Inc. Biomarker und ziele für die diagnose, prognose und handhabung von prostatkrebs
US7785842B2 (en) * 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US6759217B2 (en) * 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US8043835B1 (en) 1996-03-26 2011-10-25 Oncomedx, Inc. Methods for detecting and monitoring cancer using extracellular RNA
WO1997035589A1 (en) * 1996-03-26 1997-10-02 Kopreski Michael S Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
AU2676197A (en) * 1996-04-16 1997-11-07 Smithkline Beecham Corporation A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer
US5925519A (en) 1996-06-03 1999-07-20 The Regents Of The University Of California Genetic alterations associated with prostate cancer
JP2001503991A (ja) * 1996-11-14 2001-03-27 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ 転移性前立腺癌の検出方法
US6479263B1 (en) * 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
CA2273847C (en) * 1996-12-06 2013-08-13 Urocor, Inc. Diagnosis of disease state using mrna profiles
WO1998040513A1 (en) * 1997-03-11 1998-09-17 Ferrari Anna C Method of detecting prostate cancer metastasis
US8440396B2 (en) * 1997-03-14 2013-05-14 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US20070009934A1 (en) * 1997-03-14 2007-01-11 Kopreski Michael S Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US7659073B2 (en) 1997-04-30 2010-02-09 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
US7288636B2 (en) 1997-04-30 2007-10-30 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
ES2312186T3 (es) * 1997-04-30 2009-02-16 Hybritech Incorporated Formas del antigeno prostatico especifico y procedimientos para su deteccion.
WO1998059073A1 (en) 1997-06-20 1998-12-30 Mayo Foundation For Medical Education And Research Method for detection of breast cancer
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
EP1012343A1 (de) * 1997-09-11 2000-06-28 Abbott Laboratories Reagenzien und methoden zur detektion von prostataerkrankungen
US6300088B1 (en) 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6673914B1 (en) 1998-01-22 2004-01-06 John Wayne Cancer Institute Human tumor-associated gene
CA2330628A1 (en) 1998-05-01 1999-11-11 Queen's University At Kingston Method for diagnosing a vascular condition
US6861215B1 (en) 1998-05-21 2005-03-01 Diadexus, Inc. Method of diagnosing, monitoring, and staging prostate cancer
EP1082460A4 (de) * 1998-05-21 2003-02-12 Diadexus Inc Neuartiges verfahren zur diagnose, zur überwachung und verlaufsbeobachtung von prostatakrebs
AU5128799A (en) * 1998-07-24 2000-02-14 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pb 39, a gene dysregulated in prostate cancer, and uses thereof
US7226731B1 (en) 1998-07-24 2007-06-05 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services PB 39, a gene dysregulated in prostate cancer, and uses thereof
FR2782730B1 (fr) * 1998-08-25 2002-05-17 Biocom Sa Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede
US20060204989A1 (en) * 1998-09-22 2006-09-14 Kopreski Michael S Comparative analysis of extracellular RNA species
US8163524B2 (en) * 1998-09-22 2012-04-24 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US20090233276A1 (en) * 1998-09-22 2009-09-17 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
JP4495349B2 (ja) * 1999-01-28 2010-07-07 ジェン−プローブ・インコーポレーテッド 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列
US6156515A (en) * 1999-02-09 2000-12-05 Urocor, Inc. Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
US6875854B1 (en) 1999-11-18 2005-04-05 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
EP1421215B1 (de) * 2001-07-25 2011-03-16 Oncomedx Inc. Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
US20030104454A1 (en) * 2001-11-05 2003-06-05 Kopreski Michael S. Method for detection of DNA methyltransferase RNA in plasma and serum
US20100159464A1 (en) * 2001-11-05 2010-06-24 Oncomedx, Inc. Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
CA2432365A1 (en) * 2003-06-30 2004-12-30 Jack A. Schalken Specific method of prostate cancer detection based on pca3, and kits therefore
CN105902559A (zh) * 2005-08-01 2016-08-31 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
EP1937280B1 (de) * 2005-09-12 2014-08-27 The Ohio State University Research Foundation Zusammensetzungen zur Therapie von Bcl2-assoziierten Tumoren
AU2006302496A1 (en) * 2005-10-05 2007-04-19 The Ohio State University Research Foundation WWOX gene, vectors containing the same, and uses in treatment of cancer
EP2591794A1 (de) 2006-01-05 2013-05-15 The Ohio State University Research Foundation Anomalien bei Mikro-RNA-Expressionen in endokrinen und azinösen Pankreastumoren
EP2487253B1 (de) 2006-01-05 2015-06-24 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von festen Krebsen
WO2007081720A2 (en) 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
CN101448958A (zh) 2006-03-20 2009-06-03 俄亥俄州立大学研究基金会 人巨核细胞生成期间的微小rna指纹
ES2562607T3 (es) * 2006-07-13 2016-03-07 The Ohio State University Research Foundation MIR-21 para el diagnóstico de adenocarcinoma de colon con mal pronóstico de supervivencia
JP5426383B2 (ja) * 2006-09-19 2014-02-26 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 慢性リンパ球性白血病におけるｍｉＲ−２９およびｍｉＲ−１８１によって制御されるＴＣＬ１発現
ES2425416T3 (es) 2006-11-01 2013-10-15 The Ohio State University Research Foundation Firma de expresión del microARN para predecir la supervivencia y la metástasis en el carcinoma hepatocelular
CN101627134B (zh) * 2007-01-31 2013-11-06 俄亥俄州立大学研究基金会 用于急性髓细胞白血病（aml）的诊断、预后和治疗的基于微rna的方法和组合物
EP2481806B1 (de) * 2007-04-30 2016-11-09 The Ohio State University Research Foundation Verfahren zur Prognosis von Bauchspeicheldrüsenkrebs
ES2536907T3 (es) * 2007-06-08 2015-05-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Métodos para determinar el subtipo de un carcinoma hepatocelular
EP2167521A4 (de) 2007-06-15 2011-11-23 Univ Ohio State Res Found ONKOGENE ALL-1-FUSIONSPROTEINE ZUR ABZIELUNG AUF DROSHA-VERMITTELTE microRNA-VERARBEITUNG
EP2808398A1 (de) * 2007-07-31 2014-12-03 The Ohio State University Research Foundation Verfahren zur Reversion der Methylierung durch Targeting von DNMT3A und DNMT3B
ES2562077T3 (es) 2007-08-03 2016-03-02 The Ohio State University Research Foundation Regiones ultraconservadas que codifican ARNnc
DE102007037008B4 (de) * 2007-08-06 2015-09-10 Siemens Aktiengesellschaft Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors
ES2562078T3 (es) * 2007-08-22 2016-03-02 The Ohio State University Research Foundation Métodos y composiciones para inducir la desregulación de la fosforilación de EphA7 y ERK en leucemias agudas humanas
CA2698771A1 (en) * 2007-09-06 2009-03-12 The Ohio State University Research Foundation Microrna signatures in human ovarian cancer
US20090136942A1 (en) * 2007-09-18 2009-05-28 Oncomedx, Inc. Analysis of Extracellular RNA
CN101861401B (zh) * 2007-10-11 2014-03-12 俄亥俄州立大学研究基金会 用于诊断和治疗食管腺癌的方法和组合物
CN103898069A (zh) 2007-10-26 2014-07-02 俄亥俄州立大学研究基金会 鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途
CN101918594A (zh) * 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
AU2009219197B2 (en) * 2008-02-28 2014-04-10 The Govt. Of The U.S.A. As Represented By The Secretary Of The Dep. Of Health And Human Services MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of prostate related disorders
CN102015027A (zh) * 2008-02-28 2011-04-13 俄亥俄州立大学研究基金会 与人慢性淋巴细胞性白血病(ccl)相关的微rna特征和其用途
ES2433940T3 (es) 2008-06-11 2013-12-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Uso de la familia miR-26 como marcador predictivo del carcinoma hepatocelular y sensibilidad a la terapia
JP5960060B2 (ja) 2009-11-23 2016-08-02 ジ・オハイオ・ステート・ユニバーシティ 腫瘍細胞の増殖、遊走および浸潤に影響を与えるために有用な物質および方法
US8946187B2 (en) 2010-11-12 2015-02-03 The Ohio State University Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer
BR112013011942A2 (pt) 2010-11-15 2016-11-01 Univ Michigan formulação, forma de dosagem de droga para administração transmucosa oral, sistema transmucoso de fornecimento de droga, método de tratamento e profilaxia de uma doença ou distúrbio, método de tratamento, formulação, método para tratamento ou prevenção de carcinoma de célula escamosa de cabeça e pescoço (hnscc), método para quimioprevenção de um câncer oral ou condição pré-cancerosa, método para aumentar a concentração de uma composição de retinida, método de tratamento e profilaxia de uma doença ou condição, método de ratamento de um sujeito apresentando uma condição médica sintomática, método de tratamento de um câncer oral ou condição pré-cancerosa num paciente, método para fazer um sistema de fornecimento de droga bucal, método para aumentar a liberação e permeação de uma composição de retinida.
CN103561750A (zh) 2011-03-07 2014-02-05 俄亥俄州立大学 通过microRNA-155(miR-155)诱导的增变活性使炎症与癌症关联
CN104364390B (zh) 2011-10-14 2016-08-24 俄亥俄州立大学 与卵巢癌相关的方法和材料
US9481885B2 (en) 2011-12-13 2016-11-01 Ohio State Innovation Foundation Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
CN105936932A (zh) 2012-01-20 2016-09-14 俄亥俄州立大学 浸润性和预后的乳腺癌生物标志物标签
CN111518170A (zh) * 2020-05-09 2020-08-11 新乡医学院 基于fret的psa荧光探针、制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US5176995A (en) * 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
US5153118A (en) * 1985-12-17 1992-10-06 Eastern Virginia Medical Authority Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same
US4803169A (en) * 1986-02-05 1989-02-07 Cetus Corporation Assay for human breast cancer
US5085983A (en) * 1988-08-19 1992-02-04 City Of Hope Detection of human tumor progression and drug resistance
AU662906B2 (en) * 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
DE69332642T2 (de) * 1992-10-29 2003-10-02 Thomas Jefferson University, Philadelphia Methoden zur detektion von mikrometastasen bei prostata-krebs

Also Published As

Publication number Publication date
ES2191018T3 (es) 2003-09-01
DE69332642T2 (de) 2003-10-02
JPH08502889A (ja) 1996-04-02
US5506106A (en) 1996-04-09
CA2148350A1 (en) 1994-05-11
EP0667920A4 (de) 1998-12-16
EP0667920B1 (de) 2003-01-15
US5688649A (en) 1997-11-18
ATE231187T1 (de) 2003-02-15
PT667920E (pt) 2003-06-30
DE69332642D1 (de) 2003-02-20
EP0667920A1 (de) 1995-08-23
WO1994010343A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DK0667920T3 (da) Fremgangsmåder til påvisning af prostatacancermetastase
ATE121794T1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
FR2694754B1 (fr) Fragments d'ADN de mycobactéries, amorces d'amplification, sondes d'hybridation, réactifs et procédé de détection de détection de mycobactéries.
CA2072314A1 (en) Methods for detection of carcinoma metastases by nucleic acid amplification
ATE360808T1 (de) Unabhängiges gerät zur extraktion, amplifikation und nachweis von nukleinsäuren
AU3806701A (en) Nucleic acid detection methods using universal priming
DK1038022T3 (da) Evaluering af humane papillomavirus-tilknyttede sygdomme
ATE133715T1 (de) Verfahren zum nachweis von gesplei ter mrna
DE69607001D1 (de) Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein
NO964187L (no) Fremgangsmåte for fremstilling av mykobakterier
ES2170145T3 (es) Sustancias y procedimientos de deteccion de micobacterium tuberculosis.
FR2670797B1 (de)
PT968421E (pt) Diagnostico precoce do cancro gastrico
ATE250673T1 (de) Verfahren zur identifizierung metastatischer sequenzen
WO2002006537A3 (en) Methods of identifying renal protective factors
DK0461496T3 (da) Fremgangsmåde til kvantitativ bestemmelse af DNA-sekvenser
ATE184055T1 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
FR2694768B1 (fr) Séquences d'oligonucléotides pour la détection spécifique de mollicutes par amplication de gènes conservés.
DK0643830T3 (da) Fremgangsmåde til detektering af gastrisk epitelbeskadigelse
GB9510954D0 (en) Detection of DNA damage
FR2678285B1 (de)
DE69621791D1 (de) Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa
DE69635025D1 (de) Neues verfahren zum nachweis von cryptosporidium
WO1999058712A3 (de) Nachweis von genen